Skip to main content

Advertisement

Table 1 Participant characteristics at baseline

From: The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial

Characteristic Control (n = 16) Aerobic (n = 15) Resistance (n = 16) Combination (n = 17)
Male/Female 1/15 3/12 3/13 3/14
Age (years) 52 ± 1.8 55 ± 1.2 52 ± 1.1 53 ± 1.3
  (40 – 66) (44 – 62) (43 – 59) (43 – 64)
Weight (kg) 85.1 ± 4.2 91.9 ± 4.1 89.3 ± 4.5 90 ± 4
  (64.8 – 123) (65.9 – 124.1) (71.9 – 127.5) (62.2 – 122.3)
Body Mass Index (kg/m2) 32.4 ± 1.4 32.7 ± 1.3 33 ± 1.3 33.3 ± 1.2
  (26 – 48) (25 – 45.6) (25.8 – 44.6) (23.4 – 40.2)
Body Fat % (DXA) 46.5 ± 1.7 44.6 ± 1.9 43.7 ± 1.3 45.8 ± 1.6
  (35.9 – 59.9) (30.7 – 52.5) (34.6 – 52.2) (28.8 – 55.5)
Waist Circumference (cm) 100.3 ± 3.6 103.7 ± 2.6 104 ± 3.2 102.2 ± 3.2
  (80 – 131) (82 – 118) (83.5 – 135.5) (81.5 – 124.5)
Waist: Hip Ratio 0.85 ± 0.02 0.87 ± 0.02 0.88 ± 0.02 0.86 ± 0.02
  (0.75 – 1.01) (0.76 – 1) (0.78 – 1.03) (0.74 – 1.02)
Fasting Triglyceride (mmol/L) 1.25 ± 0.17 1.36 ± 0.19 1.27 ± 0.12 1.1 ± 0.1
  (0.48 – 2.6) (0.62 – 3.01) (0.51 – 2.14) (0.48 – 1.91)
Fasting Total Cholesterol (mmol/L) 5.51 ± 0.29 5.83 ± 0.32 5.49 ± 0.38 5.71 ± 0.31
  (2.59 – 7.12) (3.58 – 7.87) (2.92 – 8.95) (3.74 – 9.2)
Fasting HDL Cholesterol (mmol/L) 1.42 ± 0.11 1.38 ± 0.09 1.34 ± 0.08 1.43 ± 0.11
  (0.9 – 2.28) (0.91 – 1.99) (0.91 – 2.19) (0.71 – 2.08)
Fasting LDL Cholesterol (mmol/L) 3.51 ± 0.26 3.89 ± 0.3 3.56 ± 0.33 3.78 ± 0.27
  (1.42 – 5.26) (2.08 – 6.06) (1.58 – 7.02) (2.4 – 6.88)
Fasting Glucose (mmol/L) 5.35 ± 0.13 5.68 ± 0.17 5.81 ± 0.46 5.38 ± 0.13
  (4.55 – 6.22) (4.39 – 7.11) (4.91 – 7.17) (4.2 – 6.46)
HOMA2-IR 1.92 ± 0.28 1.72 ± 0.52 1.86 ± 0.18 1.86 ± 0.13
  (1 – 4.7) (0.9 – 2.5) (0.7 – 3.5) (1.2 – 2.8)
NEFA (mmol/L) 0.51 ± 0.03 0.5 ± 0.04 0.49 ± 0.04 0.46 ± 0.03
  (0.3 – 0.79) (0.17 – 0.87) (0.18 – 0.94) (0.29 – 0.7)
  1. Values are mean ± SEM and (range) for n = 64 participants at baseline. BIA: bioelectrical impedance analysis. DXA: dual-energy x-ray absorptiometry. HOMA2-IR: homeostasis model assessment of insulin resistance. NEFA: non-esterified fatty acid.